Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Vertex (Buenos Aires, Argentina)|July 24, 2007
[Cognitive performance in schizophrenia (paranoid vs residual subtype)]Carol Dillon, Fernando Taragano, Diego Sarasola, et al.International Journal of Geriatric Psychiatry|November 23, 2019
What is happening with not recommended drugs for dementia in Argentina? Prescription patterns and direct costs analysisJulian Bustin, Galeno Rojas, Santiago O'Neill, et al.Neuropsychiatric Disease and Treatment|May 5, 2009
Neuropsychiatric symptoms as a predictor of caregiver burden in Alzheimer's diseaseRicardo F Allegri, Diego Sarasola, Cecilia M Serrano, et al.International Psychogeriatrics|July 28, 2006
Economic impact of dementia in developing countries: an evaluation of costs of Alzheimer-type dementia in ArgentinaRicardo F Allegri, Judith Butman, Raúl L Arizaga, et al.Dementia & Neuropsychologia|December 8, 2017
Role of cognitive reserve in progression from mild cognitive impairment to dementiaRicardo F Allegri, Fernando E Taragano, Hugo Krupitzki, et al.Vertex (Buenos Aires, Argentina)|January 23, 2020
[Practice recommendations for the detection and diagnosis of patients with Alzheimer's disease dementia in the City of Buenos Aires]Ignacio Demey, Juan A Ollari, Galeno Rojas, et al.Vertex (Buenos Aires, Argentina)|August 11, 2012
[Review of recommendations and new diagnosis criteria for mild cognitive impairment due to Alzheimer's disease]Ricardo F Allegri, María J Russo, Janus Kremer, et al.Journal of Alzheimer'S Disease Reports|May 15, 2024
Treatment of Alzheimer's Disease in the New Era of Monoclonal Antibodies Against Cerebral Amyloid-β: Pharmacological Prescription and Knowledge in ArgentinaJonathan Cubas Guillen, Galeno Rojas, Ignacio Demey, et al.Pageof 1